Semin Reprod Med 2008; 26(2): 186-195
DOI: 10.1055/s-2008-1042957
© Thieme Medical Publishers

The Impact of Type 1 and Type 2 Diabetes Mellitus on the Oocyte and the Preimplantation Embryo

Emily S. Jungheim1 , 3 , Kelle H. Moley2 , 3
  • 1Clinical Fellow, School of Medicine, Washington University in St. Louis, St. Louis, Missouri
  • 2Professor and Vice Chair; Reproductive Endocrinology and Infertility, School of Medicine, Washington University in St. Louis, St. Louis, Missouri
  • 3Department of Obstetrics and Gynecology, School of Medicine, Washington University in St. Louis, St. Louis, Missouri
Further Information

Publication History

Publication Date:
27 February 2008 (online)

Preview

ABSTRACT

Whereas the importance of close monitoring and tight glycemic control in diabetic pregnancies cannot be ignored, the growing body of knowledge surrounding the different effects of diabetes mellitus on the earliest stages of reproduction underscores the need for aggressive screening among reproductive-aged women at risk for diabetes and the importance of preconceptual counseling among women with known diabetes. This article reviews the salient pathophysiology of type 1 diabetes and type 2 diabetes in reproduction, specifically within the context of the preovulatory oocyte and the preimplantation embryo. In doing so, this review illustrates the need for novel and safe therapies and interventions tailored to address the specific characteristics of these diseases in the periconceptual period.

REFERENCES

Kelle H MoleyM.D. 

Campus Box 8064, McDonnell Sciences Building

Room 780 B, 660 South Euclid Avenue, St. Louis, MO 63110

Email: moleyk@wustl.edu